Bond.az White LogoBond.az Black Logo

Williams Trading Upgrades Canada Goose Stock to Hold

Williams Trading upgrades Canada Goose stock to Hold. Price target C$12.00. Revenue beat estimates, but earnings missed. Wholesale revenue surged 54.4%.

Matthew King
ByMatthew King- Senior Editor
|
0

Williams Trading upgraded Canada Goose Holdings Inc. (NYSE:GOOS) to Hold from Sell with a price target of C$12.00.

The company’s fourth-quarter fiscal 2026 revenue exceeded estimates, though earnings fell short of expectations. Wholesale revenue increased 54.4% in the quarter, or 51.6% in constant currency, accounting for 10.8% of total sales, up 150 basis points year-over-year. The company maintains an impressive gross profit margin of nearly 70%, reflecting strong pricing power.

Wholesale revenue growth was driven by early deliveries of spring products originally planned for Q1 fiscal 2027 and at-once fill-in orders. Direct-to-consumer revenue increased 15.2%, or 15.8% in constant currency, driven by a 10% same-store sales increase.

The earnings miss resulted from a C$8.4 million impairment charge related to select stores. Williams Trading noted the charge will not repeat in Q4 fiscal 2027.

The firm said the stock price has closed in on its price target.

More News
Today / 11:35
|
858

Mizuho Raises STM Price Target on AI Growth

Mizuho raises STMicroelectronics price target to $68, citing AI growth and new technologies.

0
Today / 11:03
|
967

Oppenheimer Reiterates Outperform on UroGen Pharma

Oppenheimer reiterates Outperform on UroGen Pharma with $40 target. Strong commercial momentum for Zusduri driven by physician enthusiasm.

0
Today / 11:02
|
510

Guggenheim Upgrades StubHub Stock on Reset

Guggenheim upgrades StubHub stock to Buy with a $12.50 price target, citing reset expectations and growth catalysts like the World Cup.

0
Today / 10:31
|
290

Wolfe Research Initiates CytomX Stock with Outperform

Wolfe Research initiated CytomX Therapeutics (CTMX) with an outperform rating and $3.50 target. Varseta-M shows promise in colorectal cancer.

0
Today / 10:30
|
842

Wolfe Research initiates Mirum with outperform

Wolfe Research starts Mirum Pharmaceuticals with outperform rating and $145 price target, citing strong pipeline potential.

0
Today / 10:14
|
236

Wolfe Research Initiates Oklo with Peerperform

Wolfe Research initiated Oklo Inc. with a Peerperform rating. Learn about the company's targets, finances, and stock performance.

0
Today / 10:13
|
631

Aletheia Capital Reaffirms Circle Stock Rating

Aletheia Capital reaffirms Buy rating on Circle Internet Group amid U.S. stablecoin regulatory advantages. Stock at $111.39.

0
Today / 09:31
|
784

Jefferies Initiates X-Energy Stock with Hold Rating

Jefferies initiates X-Energy stock coverage with a Hold rating and $28 target. Learn about risks and recent performance.

0
Today / 09:11
|
441

UBS Upgrades Jazz Pharma on Ziihera Potential

UBS upgrades Jazz Pharmaceuticals to Buy with a $307 target on Ziihera potential. Bond.az provides detailed analysis and stock insights.

0
Today / 09:10
|
408

UBS Starts X-Energy Stock Coverage with Buy

UBS starts coverage on X-Energy stock with a buy rating and $40 target. The company's reactor model and growth potential are highlighted.

0
Today / 08:55
|
525

Goldman Sachs Upgrades Brambles on Subcontractor Exit

Goldman Sachs upgrades Brambles to Neutral after subcontractor exit. Stock drops 17%, but Bond.az analysis suggests undervaluation with $32.76 Fair Value.

0
Yesterday / 20:21
|
381

RBC Capital hikes Dominion Resources price target

RBC Capital raises Dominion price target to $72 on NextEra deal. Sector Perform rating maintained with 7% arbitrage spread.

0
...